SHE:002317 Market Cap

SHE:002317 has a market cap or net worth of 15.49 billion as of March 9, 2026. Its market cap has increased by 60.28% in one year.

Market Cap

15.49B

Enterprise Value

14.74B

Revenue

2.45B

Ranking

n/a

PE Ratio

n/a

Stock Price

18.22

Market Cap Chart

Since December 11, 2009, SHE:002317's market cap has increased from 7.22B to 15.49B, an increase of 114.63%. That is a compound annual growth rate of 4.81%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	15.49B	-4.00%
Dec 31, 2025	16.13B	56.94%
Dec 31, 2024	10.28B	-24.46%
Dec 29, 2023	13.61B	-37.64%
Dec 30, 2022	21.82B	126.34%
Dec 31, 2021	9.64B	8.90%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shenzhen Hepalink Pharmaceutical Group	15.29B
Hybio Pharmaceutical	15.19B
China Resources Jiangzhong Pharmaceutical Co.,Ltd	15.65B
Nanjing King-Friend Biochemical Pharmaceutical	15.66B
Shenzhen Kangtai Biological Products	15.73B
Zhejiang Jiuzhou Pharmaceutical	14.83B
Guobang Pharma	14.74B
Shanghai Shyndec Pharmaceutical	14.52B

Market Cap Rankings